Related Experiment Video
Updated: Jun 9, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Association of a Novel Dietary Index Assessing Gut Microbiota Impact With Rheumatoid Arthritis: A Nationwide
Zhi-Ling Li1, Yao-Wei Zou2, Pei-Wen Jia2
1Department of Rheumatology and Immunology The First People's Hospital of Zhaoqing Zhaoqing China.
None:
Growing research implicates the diet-microbiota-joint axis plays a key role in joint health. The Dietary Index for Gut Microbiota (DI-GM) is a novel metric evaluating dietary effects on microbial communities, yet its potential link to rheumatoid arthritis (RA) is unestablished. This study aimed to assess the relationship between DI-GM scores and RA. We conducted a cross-sectional analysis of 29,656 participants using data from the National Health and Nutrition Examination Survey (NHANES) 2007-2020. DI-GM scores were derived from 24-h dietary recalls, and RA status was defined by self-reported physician diagnosis. Weighted logistic regression was used to evaluate the association between DI-GM and RA prevalence. Among included participants (weighted mean age 44.01 years; 49.48% female), 7.16% reported RA. After comprehensive adjustment, a significant inverse correlation was observed: each unit increase in DI-GM score correlated with a 5.7% decrease in the odds of RA prevalence (odds ratio [OR] = 0.943; 95% confidence interval [CI]: 0.898-0.991). Individuals scoring DI-GM ≥ 7 exhibited a 27.2% lower odds of having RA compared to those scoring ≤ 4 (OR = 0.728, 95% CI: 0.576-0.920). Restricted cubic spline analysis indicated a linear dose-response relationship (p for nonlinear = 0.304). Furthermore, no significant subgroup interactions were detected (all p for interaction > 0.05). Our study found that higher DI-GM scores linearly associate with diminished RA prevalence among US adults, highlighting a potential link between diet-modulated gut microbiota and RA.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics